Literature DB >> 8881449

Overnight metabolic fuel deficiency in patients treated conventionally for hypopituitarism.

K A Al-Shoumer1, K Ali, V Anyaoku, R Niththyananthan, D G Johnston.   

Abstract

BACKGROUND: Hormone replacement in hypopituitary adults attempts to reproduce normal physiology. Conventional regimens fail to mimic normal hormone profiles over 24 hours.
OBJECTIVE: To investigate the metabolic consequences of conventional hormone replacement in hypopituitary adults by measuring circulating levels of the major fuels, glucose, non-esterified fatty acids (NEFA), glycerol and 3-hydroxybutyrate (3-OHB) over 24 hours in hypopituitary subjects and controls.
SUBJECTS: Ten GH and adrenocorticotrophin deficient hypopituitary adults on conventional replacement and 13 controls matched for age, sex and body mass index were studied. The patients received replacement with hydrocortisone twice daily (at 0730 and 1730 h; mean (range) daily dose 22 (10-30) mg/24 h) but not with GH. Other hormones were replaced as clinically necessary. MEASUREMENTS: Circulating glucose, NEFA, glycerol and 3-OHB levels were measured over 24 hours together with concentrations of cortisol (total and free), GH and insulin, and urinary free cortisol.
RESULTS: Levels of glucose, NEFA and 3-OHB were lower in patients than controls (mean +/- SEM) (4.3 +/- 0.1 vs 5.3 +/- 0.1 mmol/l, P = 0.0001; 291 +/- 46 vs 448 +/- 48 mumol/l, P = 0.015; 78 +/- 8 vs 136 +/- 24 mumol/l, P = 0.035, respectively) before breakfast. This decrease in glucose, NEFA and 3-OHB was observed in the patient group throughout the night, from midnight to breakfast. For NEFA, the decrease persisted throughout the 24 hours. Glycerol did not differ significantly in patients and controls. Integrated levels of total and free plasma cortisol, and 24-hour urine cortisol excretion, were normal in patients but total and free plasma cortisol concentrations overnight were markedly decreased (overnight area under the curve (AUC) of total cortisol: 440 +/- 154 vs 1593 +/- 267 nmol/l h, P = 0.0024; overnight AUC of free cortisol: 24 +/- 8 vs 161 +/- 26 nmol/l h, P = 0.0001). GH levels were low throughout the whole 24 hours in the patient group (24-hour AUC: 10.6 +/- 5.1 vs 74.6 +/- 19.6 mU/l h, P = 0.008).
CONCLUSIONS: Hypopituitary adults on conventional hormone replacement regimens have low concentrations of metabolic fuels, glucose, non-esterified fatty acids and 3-hydroxybutyrate throughout the night, possibly related to GH deficiency or to decreased overnight circulating cortisol levels. This overnight fuel deficiency may underlie the mechanism for the non-specific symptoms, such as fatigue and headache in the early morning, which are frequent in this group of patients.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8881449     DOI: 10.1046/j.1365-2265.1996.d01-1552.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  7 in total

1.  Increase in serum pregnancy-associated plasma protein-A is correlated with increase in cardiovascular risk factors in adult patients with growth hormone deficiency.

Authors:  Linman Li; Wei Ren; Jinchao Li; Jingjing Liu; Lingli Wang; Xiaoya Zheng; Dezhen Liu; Sufang Li; Rhonda Souvenir; Jiping Tang
Journal:  Endocrine       Date:  2012-05-29       Impact factor: 3.633

Review 2.  Anterior pituitary hormone replacement therapy--a clinical review.

Authors:  Christoph J Auernhammer; George Vlotides
Journal:  Pituitary       Date:  2007       Impact factor: 4.107

3.  Pharmacokinetic evidence for suboptimal treatment of adrenal insufficiency with currently available hydrocortisone tablets.

Authors:  Nicolas Simon; Frederic Castinetti; Floriane Ouliac; Nathalie Lesavre; Thierry Brue; Charles Oliver
Journal:  Clin Pharmacokinet       Date:  2010-07       Impact factor: 6.447

4.  [Reduced incidence of side-effects of growth hormone substitution in 404 patients with hypophyseal insufficiency. Results of a multicenter indications study].

Authors:  C Wüster; U Melchinger; T Eversmann; J Hensen; P Kann; A von zur Mühlen; M B Ranke; H Schmeil; H Steinkamp; U Tuschy
Journal:  Med Klin (Munich)       Date:  1998-10-15

Review 5.  Pituitary disorders. Drug treatment options.

Authors:  J J Orrego; A L Barkan
Journal:  Drugs       Date:  2000-01       Impact factor: 9.546

6.  Fasting during the ramadan: a challenge for patients with adrenal insufficiency.

Authors:  Miguel Debono
Journal:  Endocrine       Date:  2017-05-20       Impact factor: 3.633

7.  A phase 2 study of Chronocort, a modified-release formulation of hydrocortisone, in the treatment of adults with classic congenital adrenal hyperplasia.

Authors:  Ashwini Mallappa; Ninet Sinaii; Parag Kumar; Martin J Whitaker; Lori-Ann Daley; Dena Digweed; David J A Eckland; Carol Van Ryzin; Lynnette K Nieman; Wiebke Arlt; Richard J Ross; Deborah P Merke
Journal:  J Clin Endocrinol Metab       Date:  2014-12-11       Impact factor: 5.958

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.